Jim VanderSteeg, President and CEO at Covenant Health, shared a post on LinkedIn:
“I’m thrilled to announce that Covenant Health is welcoming two nationally recognized oncology leaders to our Cancer Care team: Dr. David Penberthy as Executive Medical Director of the Oncology Service Line, and Dr. Susan Newman as Medical Director of Medical Oncology and Breast Cancer Program.
These appointments mark a major milestone in our commitment to delivering exceptional, patient-centered cancer care.
Every year, Covenant Health treats over 5,000 new cancer patients—and with the addition of Dr. Penberthy and Dr. Newman, we’re strengthening our ability to provide advanced, personalized treatment across the region.
Dr. Penberthy brings national expertise in radiation therapy and oncology innovation, including leadership roles and recent service as President of the Association of Cancer Care Centers.
Dr. Newman has spent over two decades caring for patients in East Tennessee and will lead the continued growth of our breast cancer and medical oncology services.
Together, they will help expand access to cutting-edge treatments like proton therapy and drive innovation across our oncology programs.
This is a bold step forward in our vision to be the first and best choice for patients fighting cancer.”
More posts featuring David Penberthy